⌘K

Login Start Free

Home/Filings/4/0001213900-20-000983

4//SEC Filing

Friedman Aviad 4

Accession 0001213900-20-000983

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:04 PM ET

Size

5.5 KB

Accession

0001213900-20-000983

Insider Transaction Report

Form 4

Period: 2020-01-08

ORAMED PHARMACEUTICALS INC.ORMP

Director

Transactions

Award
Stock Option (right to buy)
2020-01-08+20,000→ 20,000 total
Exercise: $4.80Exp: 2030-01-08→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The Stock Option will vest in 3 installments as follows: 6,666 shall vest on December 31, 2020, and 6,667 shall vest on each of December 31, 2021 and December 31, 2022.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001683729

Filing Metadata

Form type: 4
Filed: Jan 13, 7:00 PM ET
Accepted: Jan 14, 4:04 PM ET
Size: 5.5 KB

View on SEC.gov